Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 322.31K P/E - EPS this Y - Ern Qtrly Grth -
Income -985.39k Forward P/E - EPS next Y - 50D Avg Chg -
Sales - PEG - EPS past 5Y - 200D Avg Chg 37.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -61.00%
Recommedations - Quick Ratio 0.66 Shares Outstanding 153.48M 52W Low Chg 2,000.00%
Insider Own 18.16% ROA -9.43% Shares Float - Beta -7.78
Inst Own - ROE - Shares Shorted/Prior -/- Price 0.00210
Gross Margin - Profit Margin - Avg. Volume 5,300 Target Price -
Oper. Margin - Earnings Date - Volume 128,500 Change 0.00%
About REGENICIN INC

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.